Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
19.99
+0.34 (1.73%)
At close: Nov 4, 2026, 4:00 PM EST
19.90
-0.09 (-0.45%)
After-hours: Nov 4, 2026, 7:30 PM EST
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $516.55 million as of November 4, 2026. It is the 14,173rd most valuable company in the world and the 2,713th biggest in the United States. Its market cap has increased by 4,656.57% in one year.
Market Cap
516.55M
Enterprise Value
341.90M
1-Year Change
4,656.57%
Global Rank
Country Rank
#2,713 United States
Category
ChartMarket Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has decreased from $558.65M to $516.55M, a decrease of -7.54%. That is a compound annual growth rate of -1.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 516.55M | 3,738.25% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 509.91M |
| CytomX Therapeutics | 509.88M |
| Electra Therapeutics | 508.41M |
| Surrozen | 508.06M |
| DiaMedica Therapeutics | 498.81M |
| Ovid Therapeutics | 496.06M |
| Gyre Therapeutics | 482.98M |
| REGENXBIO | 475.29M |